ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Cash & Equivalents Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 20.63% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -21.29% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 186.05% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 22.30% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 21.60% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 11.90% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 12.96% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -2.16% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -5.74% |
| 10 | ENDRA Life Sciences | 5.18 Mn | 4.83 Mn | - | -82.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.74% |
| Dec 31, 2025 | -76.39% |
| Sep 30, 2025 | -83.27% |
| Jun 30, 2025 | -71.74% |
| Mar 31, 2025 | 81.98% |
| Dec 31, 2024 | 13.96% |
| Sep 30, 2024 | 42.30% |
| Jun 30, 2024 | 32.81% |
| Mar 31, 2024 | -51.82% |
| Dec 31, 2023 | -42.04% |
| Sep 30, 2023 | -58.40% |
| Jun 30, 2023 | -57.27% |
| Mar 31, 2023 | -66.95% |
| Dec 31, 2022 | -48.33% |
| Sep 30, 2022 | -32.03% |
| Jun 30, 2022 | -19.69% |
| Mar 31, 2022 | -57.68% |
| Dec 31, 2021 | 30.91% |
| Sep 30, 2021 | 210.90% |
| Jun 30, 2021 | 1,776.04% |